JPMorgan maintains DexCom at Overweight, PT $150.00

  • Investing.com
JPMorgan maintains DexCom at Overweight, PT $150.00

A JPMorgan analyst maintained DexCom (NASDAQ: DXCM) at Overweight and a price target of $150.00 from a prior price target of %currency%%price%.

Prior to this rating, DexCom had 17 buy ratings, 3 hold ratings, and 1 sell ratings.

For consensus analyst estimates and price targets on DexCom, click here. For more news on DexCom, click here.

DexCom's stock price closed at $123.58. They are up 8.02% in the last month and up 18.76% in the last 12 months.

According to Investing Pro, DexCom's fair value is $89.29, a downside of 26.70%. DexCom's fair value comes with a medium degree of uncertainty, according to InvestingPro.

Check out DexCom's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles